Call for Proposals: Proposed Experiments to be performed at the International Space Station - Astronaut for Israeli Science & Education (AISE)
Summary
This document is a formal Call for Proposals issued jointly by the Ramon Foundation and the Israel Space Agency for scientific experiments and technology demonstrations to be conducted aboard the International Space Station (ISS) during the Axiom Space Ax-1 mission with Israeli astronaut Eytan Stibbe. It provides general background, scope, resources, submission instructions, selection criteria, timeline, mutual non-disclosure agreement templates, and lists of implementation partners and scientific committee members.
Page 1 - Introduction
Ramon Foundation Call Proposal Submission Period: December 22th 2020 to February 28st 2021
Call for Proposals
Proposed Experiments to be performed at the International Space Station Astronaut for Israeli Science & Education (AISE) General Background and Instructions
INTRODUCTION
The Ramon Foundation, non-governmental organization (NGO), that promotes themes of space and aviation aiming to encourage personal excellence and community involvement, together with the Israeli Space Agency at the Israeli Ministry of Science and Technology, are pleased to announce this call for proposals. We wish to follow in Ilan Ramon’s footsteps and empower the Israeli space eco-system.
In November 2020, we announced the first Israeli private astronaut’s mission, the second Israeli in space, Mr. Eytan Stibbe, who will fly on a ten-day mission onboard the Axiom Space Ax-1 Flight, the first ever commercial human spaceflight mission to the International Space Station (ISS).
One of the central pillars of AISE mission is to support the promotion of the Israeli space sector and enhance innovation in the field while simultaneously positioning Israel as a global innovation player for space technologies.
To lower the entry barriers to the space sector, the Ramon Foundation and the Israeli Space Agency at the Ministry of Science and Technology encourage Israeli scientists, researchers, startups and other entities to participate in this proposed mission and gain access to ISS scientific and tech platforms collaboration with Mr. Stibbe on this historic AISE mission.
Page 2 - Call for Proposals Scope
CALL FOR PROPOSALS SCOPE
This is a call for proposals for utilizing astronaut operating time during the Ax-1 mission, from launch to landing, Astronaut will be available for briefing, practice and preparations in Israel prior to the launch and for debriefing and summary after landing.
This call is open to any Israeli organization or team that wishes to conduct experiments or demonstrate technologies aboard the ISS: Academic Institutes, research centers, not-for-profit organizations, entrepreneurs, startups, and commercial organizations. Collaboration between any of these, including with international partners, is encouraged.
This solicitation will consider ANY area of science/technology which can be performed at the International Space Station as part of Mr. Stibbe’s AISE mission. Submitted proposals should demonstrate and explain the innovative approach of the project.
This opportunity is enabled by Axiom Space, Inc., a privately owned U.S. company building the world’s first commercial space station as the eventual replacement to the ISS and the only company authorized to plan, train, and manage commercial missions with private astronaut customers to the ISS.
The Ax-1 mission is set to launch aboard a SpaceX Crew Dragon. To achieving the objectives of AISE mission on the Ax-1 mission, some experiment cargo may need to be launched to the ISS ahead of the Ax-1 mission. Axiom Space has an active relationship with the ISS National Lab that, among other things, permits Axiom to request and obtain transportation for Axiom customer cargo to/from the ISS on ISS Program sponsored cargo missions.
Page 3 - Resources
RESOURCES
The Proposers • All costs, including project development, modifications, packaging, shipping, and implementation partner services to conduct experiment in orbit are the responsibility of the proposers. • Cargo capacity to the ISS is limited. All proposals will be considered equally but smaller payloads to orbit may be easier to implement on the Ax-1 mission.
Ramon Foundation • Ramon Foundation will provide Astronaut operating time to perform the research/project/test. • Ramon Foundation gathered scientific-technological committee including top-level multidisciplinary experts from academic institutes, governments, and space agency. This committee will perform the proposals evaluation and selection process.
The Israeli Space Agency at the Ministry of Science and Technology • The Israeli government intends to publish during the first quarter of 2021 a call for research proposals in the area of Science and Technology to be carried out on the ISS, with government funding. Submission will be open, inter alia, to the proposes selected by this call. (Note 1: The mentioned call for proposals is subject to the committee for special financial engagement approval appointed by the accountant general at the ministry of finance. Should the committee reject the request this call for proposals will be cancelled.) • The Israeli Space Agency intends to contact national space agencies (NASA, ESA, etc.) and request access to their facilities onboard the ISS, if required, and subject to the approval of each agency.
Axiom Space • Some selected proposals may need to pre-position their supplies and hardware on one of these earlier cargo missions. Axiom will provide all arrangements for this service. • For non-governmental facilities at the ISS, Axiom space will facilitate the required arrangements. • Each of the selected proposers will sign an agreement with Axiom Space to access to the Ax-1 mission and for any implementation partner services required on the mission and the ISS.
Page 4 - Proposal Preparation and Submission Instructions
PROPOSAL PREPARATION AND SUBMISSION INSTRUCTIONS
All proposers must submit the following to the submission box located in ramonfoundation.org.il by 6:00 p.m. (IST) on February 28, 2021:
- Cover page (1-page)
- Proposal (up to 10-pages)
- Budget breakdown (1-page)
- Reference list (optional; 1-page)
- Quad chart (1-page)
- Abstract (100 words)
- Proposal Schedule (1-page)
- Safety
- Agreement with providers
- Collaborations descriptions
- Ethical certification if required (Helsinki committee, IRB (Independent Review Board) IEC (independence ethics committee)
Templates for the cover page, proposal, quad chart, and budget breakdown are included in the package found online at the Ramon Foundation website. All submitted documents must adhere to instructions printed in blue. Proposers must use 1-inch margins and 12-point standard font (Times or Arial).
NOTE: Proposers have the responsibility to clearly explain critical details needed for the committee to properly assess the proposal. Proposers should not assume that committee are experts in the specific area, nor that the reviewers will look at any material other than what is provided in the proposal.
Page 5 - General Selection Process
General Selection Process
All proposals will be evaluated by a panel of multidisciplinary experts from academic institutes, government, and space agency.
Proposals selection process will be according to the following process: [Workflow Stages:]
- Initial Evaluation: Pass/no pass based on threshold criteria
- Feasibility Evaluation by Axiom Space
- Proposals Classification to Disciplines
- Disciplines sub-committee review
- Each Discipline Top 5 Selection
- Proposers Pitch Date (Optional)
- Final Selection (+Backup list)
The proposals will be evaluated according to the following prerequisites: • Technical feasibility of the experiment to be conducted on the ISS. • Availability of required ISS and commercial partner resources based on Ax-1 mission timeline. • Scientific and Economic impact, novelty, and breakthrough.
Page 6 - Schedule
Schedule
• Call for Proposals Webinar and Q&A Submission Due Date (by mail): December 29, 2021 [sic - 2020] • Q&A Document publish on the webpage: January 5, 2021 • Private providers for ISS payload services webinars week: January 11-14, 2021 • Proposals Due Date: February 28, 2021 • Feasibility Review: February 15-21, 2021 • Proposer Pitch conference (optional): February 21, 2021 • Final Selection and announcement of the Selected Proposals: February 28, 2021 • Verification Plan Reviews: March-April 2021 • Verification Results Report Submission: July 15, 2021 • Ready to launch Design Review: August 1, 2021 • Earlier launch due date (Optional): September 1, 2021 • Ready to Launch: October 1, 2021
*changes in the schedule are expected
Page 7 - List of Annexes
List of Annexes
I. List of Implementation Partners for International Space Station (ISS) Services II. NDA FORMAT-Non-Disclosure Agreement III. Ramon Scientific Committee Members IV. Pre-Position Opportunities
Page 8 - Annex I: List of Implementation Partners for ISS Services
ANNEX I List of Implementation Partners for International Space Station (ISS) Services *Facilities and Capabilities overview on the International Space Station (ISS) can be found at the following link: https://www.nasa.gov/mission_pages/station/research/browse_facilities.
The Ramon Foundation and the Israeli Government will be able to negotiate with national space agencies (NASA, ESA, etc.), if their facilities are required. For other facilities, at the ISS, Axiom space will facilitate the required arrangements.
Implementation Partners:
- Alpha Space | Website: https://www.alphaspace.com/ | Contact: Mark Shumbera ([email protected])
- Axiom Space | Website: https://www.axiomspace.com/ | Contact: Christian Maender ([email protected])
- BioServe | Website: https://www.colorado.edu/center/bioserve/ | Contact: Stefanie Countryman ([email protected])
- ETC | Website: https://www.iai.co.il/p/etc | Contact: Ron Raz ([email protected])
- HNu Photonics | Website: http://scorpiov.com/ | Contact: Devin Ridgley ([email protected])
- ICECUBES | Website: https://www.icecubesservice.com/ | Contact: Hilde Stenuit ([email protected]) / Mauro Ricci ([email protected])
- NanoRacks | Website: https://nanoracks.com/ | Contact: Ajeeth Ibrahim ([email protected])
- Ramon Space | Website: https://www.ramon.space/ | Contact: Dror Reznik ([email protected])
- SpacePharma | Website: www.space4p.com | Contact: Lihi Efremushkin ([email protected])
- Space Tango | Website: https://spacetango.com/ | Contact: Jana Stoudemire ([email protected])
- Techshot | Website: https://techshot.com/aerospace/technology/ | Contact: Rich Boling ([email protected])
Page 9 - Annex II: Mutual Non-Disclosure Agreement (Part 1)
ANNEX II MUTUAL NON DISCLOSURE AGREEMENT
This Mutual Non Disclosure Agreement (the “Agreement”) is entered into as of __________ (the “Effective Date”), by and between the Ramon Foundation, an Israeli registered association (the “Foundation”), and ________________________, [Foundation number/Passport Number] ____________, having its principal place of business at _________________ (the “Applicant”).
WHEREAS the Foundation, and an committee appointed and acting on behalf of the Foundation (the “Committee”), wishes to evaluate Applicant’s proposal, submitted with respect to the Call for Proposal for Experiments to be Performed at the International Space Station, dated ________ (the “Purpose”), in the course of which Recipient may be exposed to certain Confidential Information (as such term is defined herein); and
WHEREAS each Party is willing to provide the other Party (as applicable, the “Discloser” to the “Recipient”) with such Confidential Information, provided the Confidential Information is properly protected and preserved from dissemination or improper use;
NOW THEREFORE, each Party, as Recipient, intending to be legally bound, hereby undertakes towards the other Party as follows:
- Confidential Information 1.1. All information disclosed by the Discloser to the Recipient, whether in tangible form (including electronic or magnetic media) or verbally (the “Confidential Information”), shall be deemed furnished in confidence and shall be subject to the terms and conditions hereunder. For the avoidance of doubt, the term “Discloser” shall be deemed to include any and all of Discloser’s affiliates (i.e. entities directly or indirectly under control, common control, or in control of Discloser). 1.2. By way of illustration, such Confidential Information shall include any information that by its nature may be deemed as confidential or proprietary, as well as, inter alia, the following information, however documented or disclosed – (i) any and all information regarding software, hardware, prototypes, product specifications, data, trade secrets, research, software codes and designs, algorithms, patent applications, laboratory notebooks, sequences, regulatory information, medical reports, clinical data and analysis, reagents, cell lines, biological materials, know-how, processes, formulas, methods, inventions and ideas, past, current and planned development or experimental work, systems and structures of the Discloser, and any other information, however documented of the Discloser; (ii) any and all information concerning the business of the Discloser (which may include legal information, financial statements and projections, forecasts, plans, key personnel, training, techniques, materials, customer lists, price lists and market studies)…
Page 10 - Annex II: Mutual Non-Disclosure Agreement (Part 2)
…market studies); (iii) information of third parties as to which the Discloser may have an obligation of confidentiality; and (iv) any and all notes, analysis, studies, summaries, and other material containing or based, in whole or in part, on any information included in the foregoing.
1.3. Confidential Information shall not include information which the Recipient can prove: (i) is in, or becomes part of the public domain through no wrongful act of the Recipient or on his behalf; (ii) was already known to Recipient prior to disclosure by the Discloser; (iii) is later disclosed to Recipient by a third party who is under no confidentiality obligation as to the information involved; or (iv) was independently developed or discovered by the Recipient without use of the Discloser’s Confidential Information. 1.4. Confidential Information shall not be deemed to be in the public domain merely because any part of the Confidential Information is embodied in general disclosure or because individual features, components or combinations thereof are now or become known to the public. 1.5. For the avoidance of doubt, disclosure of the terms and the existence of this Agreement by a Party in connection with a due diligence inquiry and subject to confidentiality undertakings similar to the terms hereof shall not be considered to be a breach of this Agreement.
- Secrecy 2.1. The Recipient acknowledges that its access to any Confidential Information is essential to the performance of the Purpose, and that the Confidential Information is disclosed solely for such Purpose. 2.2. The Recipient further recognizes and acknowledges that the Confidential Information is a valuable and unique asset of the Discloser, and that its use or disclosure would cause the Discloser substantial loss and damages. 2.3. The Recipient undertakes and agrees as follows: 2.3.1. It will hold all Confidential Information in complete confidence, exercising at least the same degree of care as used by it to protect its own proprietary or Confidential Information, and in any event no less than a reasonable degree of care for the relevant type of Confidential Information. 2.3.2. It will restrict disclosure of the Confidential Information solely to those Representatives (as such term is defined herein), whose knowledge of the Confidential Information is necessary for the Purpose, and subject to those Representatives receiving the Confidential Information undertaking confidentiality obligations at least restrictive as set forth herein. 2.3.3. It will not make use of any such Confidential Information for its own purposes or for the benefit of any other party.
Page 11 - Annex II: Mutual Non-Disclosure Agreement (Part 3)
2.3.4. It will not reproduce any of the Confidential Information without the Discloser’s prior written consent. 2.3.5. It will not copy, modify, create any derivative work of, or include in any of its products or publications the Confidential Information or any portion thereof. 2.3.6. It will not reverse assemble, decompile, reverse engineer, analyze or otherwise attempt to identify the Confidential Information or derive the underlying ideas, algorithms, formulas, formulations, components, structure, methods, designs or organization) from the Confidential Information, or any part thereof. 2.3.7. It shall be responsible for any breach of this Agreement by its Representatives (including Representatives who hereafter become former Representatives), and shall take all steps as may be reasonably necessary to prevent unauthorized use or disclosure of the Confidential Information by its existing or former Representatives. 2.3.8. For purposes of this Agreement, the term “Representatives” shall mean the Recipient and its respective employees, consultants, attorneys or other agents and/or third parties that may gain access to the Confidential Information through the Recipient.
2.4. In the event Recipient is required to disclose any Confidential Information as a result of court order or other legal process, it shall be entitled to disclose such Confidential Information to the relevant legal authority provided that (i) it will provide Discloser with prompt prior notice of such requirement in order to provide Discloser an opportunity to take legal action to prevent or limit the scope of such disclosure; (ii) it shall limit disclosure to the required minimum. 2.5. The Recipient will not disclose or otherwise make available to the Discloser in any manner any confidential information received by it from third parties. The obligations set forth in this section are perpetual, and shall survive termination of any Recipient’s engagement with the Discloser, for any reason whatsoever.
-
Return of Materials. Upon termination or expiration of this Agreement, or upon receipt of a request of the Discloser, the Recipient will promptly deliver to the Discloser all copies of all written and tangible material, in its possession or under its control, incorporating the Confidential Information, without retaining any copies thereof, except for one archival copy that may be retained by the Recipient’s legal counsel to monitor compliance with the terms of this Agreement only.
-
No Licenses. Nothing in this Agreement shall be construed as granting or conferring upon the Recipient any rights by license or otherwise, expressly, impliedly or otherwise for any product, service, invention, discovery or improvement arising out of the Confidential Information supplied by the Discloser pursuant to this Agreement.
Page 12 - Annex II: Mutual Non-Disclosure Agreement (Part 4)
-
Confidentiality Period The rights and obligations of the parties under this Agreement shall continue in full force and effect for a period of seven (7) years following the date of the disclosure of the Confidential Information, provided that any trade secrets shall remain confidential until such are qualified under one of the exclusions set forth in Section 1.2 above.
-
Miscellaneous. 6.1. Recipient acknowledges that the value of the Confidential Information provided by the Discloser is attributable substantially to the fact that the Confidential Information is maintained by the Discloser in confidence and is unavailable to others without the expenditure of substantial time, effort, or money. Recipient therefore covenants and agrees to keep strictly secret and confidence the Confidential Information in accordance with the provisions of this Agreement, and represents, warrants, and agrees that it will neither use nor permit to be used, directly or indirectly, such Confidential Information except as expressly specified in this Agreement, nor will Recipient use or permit use to be made of the Confidential Information by or for the benefit of any third party. Recipient agrees to safeguard the Confidential Information and to prevent disclosure or other dissemination thereof to any third party 6.2. Recipient acknowledges Discloser shall have no obligation to enter into any business engagement with the Recipient. 6.3. The Discloser may enforce this Agreement and any of its provisions by injunction, specific performance or other equitable relief, without placing a bond or proving actual damages and without prejudice to any other rights and remedies that the Discloser may have for the breach of this Agreement. 6.4. If any portion of this Agreement shall be adjudicated to be invalid or unenforceable, it shall be deemed to be amended to delete such portion. 6.5. This Agreement shall be enforced to the fullest extent permissible under the laws of the State of Israel, without regard to its conflict of law principles. 6.6. The Parties expressly consent to the exclusive personal jurisdiction of the competent courts in Tel-Aviv for any lawsuit arising from or relating to this Agreement.
IN WITNESS WHEREOF, the parties have executed this Agreement as of the date written first above.
The Ramon Foundation By: ________________ Title: ________________
[Applicant: ________________] By: ________________ Title: ________________
Page 13 - Annex III: Ramon Scientific Committee Members
ANNEX III Ramon Scientific Committee Members
• Mrs. Inbal Kreiss (Chairperson): Head of Innovation, Systems Missiles and Space Division, Israel Aerospace Industries • Mr. Avi Blasberger (Committee Member): Director, Israel Space Agency, Ministry of Science and Technology • Dr. Osnat Luxenburg (Committee Member): Head of the Medical Technologies, Information and Research Division, Ministry of Health • Mr. Tzachi Shenrach (Committee Member): Head of the Technologies and Market Industries Division, Deputy Director of Innovation Authority • Prof. Avishay Eyal (Committee Member): Head of the Optics and Photonics Laboratory, Program head of undergrad studies at the School of Electrical Engineering, Faculty of Engineering, Tel Aviv University • Prof. Dan Blumberg (Committee Member): Head of the Remote Sensing and Imaging Laboratory, Vice President of Regional-Industrial Development, Ben Gurion University • Prof. Dror Harats (Committee Member): Faculty member in Sackler School of Medicine at Tel Aviv University, Head of Research Authority at Sheba Medical Center, CEO and founder of VBL Biotech Co. • Prof. Ehud Behar (Committee Member): Dean of the Faculty of Physics, Astrophysicist, Former Director of Asher Space Center, Technion – Israel Institute of Technology • Dr. Jacob Cohen (Committee Member): Chief Scientist, NASA Ames Research Center, Ramon Foundation advisor • Prof. Orit Shefi (Committee Member): Head of Bio-Engineering Program, Member at the Institute of Nanotechnologies and Neuro-Science, Faculty of Engineering, Bar Ilan University • Dr. Shir Stibbe (Committee Member): Donors Representative, Pediatrics Resident, Sheba Medical Center • Mr. Eliran Raphael Hamo (Committee Coordinator): Researcher in the Department of Materials Science and Engineering, Faculty of Engineering, Tel Aviv University
Page 14 - Annex IV: Notional Cargo Pre-Position Opportunities
ANNEX IV Notional Cargo Pre-Position Opportunities (Flights) to the ISS
- SpaceX-23 (Cargo Dragon 2)
- Launch Date: August 18, 2021
- Schedule and comments: Regular soft-stow cargo is usually delivered to the ISS packing contractor ~45-60 days before launch. Late load and powered cargo is usually delivered 1-7 days before launch.
- SNC-1 (Dream Chaser)
- Launch Date: September 14, 2021
- Schedule and comments: First launch of a new vehicle which will likely drive earlier than normal cargo delivery of 60-90 days for regular soft stow cargo. Late load and powered cargo is usually delivered 1-7 days before launch.
- SpX-24 (Cargo Dragon 2)
- Launch Date: November 2021
- Schedule and comments: Regular soft-stow cargo is usually delivered to the ISS packing contractor ~45-60 days before launch. Late load and powered cargo is usually delivered 1-7 days before launch.